(1 ,uM). Forskolin (1-1,000 gM) mimics the isoproterenol-induced response. In contrast, a-adrenergic agonist phenylephrine (1-100 ,uM) inhibits the secretion. Pretreatment of BAECs with captopril (1 ,M) inhibits the accumulation of angiotensin II and angiotensin III in the culture medium, but not angiotensin I. These findings suggest that BAEC production and/or secretion of angiotensins is regulated by adrenergic mechanisms. (Circulation Research 1990;66:103-108) 
. Forskolin (1-1,000 gM) mimics the isoproterenol-induced response. In contrast, a-adrenergic agonist phenylephrine ,uM) inhibits the secretion. Pretreatment of BAECs with captopril (1 ,M) inhibits the accumulation of angiotensin II and angiotensin III in the culture medium, but not angiotensin I. These findings suggest that BAEC production and/or secretion of angiotensins is regulated by adrenergic mechanisms. (Circulation Research 1990;66:103-108) T he classic concept of the renin-angiotensin system is that it is a blood-borne hormonal system in which renin and angiotensinogen are secreted into the circulation by the kidney and liver, respectively. Angiotensin I (Ang I), the product of renin-angiotensinogen reaction, is cleaved by the angiotensin converting enzyme (ACE) in the blood and on endothelial cells to the vasoactive peptide, angiotensin II (Ang II). This peptide acts on its multiple target organs1-3 and contributes importantly to the regulation of the cardiovascular system.
With the application of biochemical and molecular biological techniques, the essential components of the renin-angiotensin system have also been found in various tissues such as vascular wall,4,5 heart, kidney, adrenal, and brain. 6 
Experimental Protocols
All experiments were carried out with cell cultures between 10-15 passages. Cells were allowed to grow to confluency in DMEM supplemented with 10% calf serum. At confluency, cell medium was removed and washed twice with DMEM containing 0.2% crystalline bovine serum albumin (BSA) (GIBCO Laboratories, Grand Island, New York). This will be referred to as assay medium. Both calf serum and BSA were heat-inactivated so that they contained no detectable renin or renin substrate activities.9 After 4-hour incubation of BAECs in fresh assay medium, cells were then treated with isoproterenol, phenylephrine, or forskolin. Both control and treated cells were incubated for 30 minutes at 37 C. To obtain a sufficient amount of angiotensin for detection, 18-20 culture dishes were used for each experimental condition. The culture media and cell lysates were pooled for the measurement of angiotensins.
High-Performance Liquid Chromatography and Radioimmunoassay
The procedure of extraction of angiotensin from cells or media is based on the method of Kifor and Dzau.9 The pooled media were immediately mixed with trifluoroacetic acid (TFA, final concentration 4% vol/vol) and heated to boiling. The protein precipitate was removed by centrifugation, and the supernatant was applied to an RP 18 SEP PAK cartridge (Waters Associates, Milford, Massachusetts). After washing with 0.01 M TFA, the columns were eluted with 80% acetonitrile in 0.01 M TFA. The eluate was lyophilized, dissolved in 0.02 M acetic acid, filtered, and subjected to high-performance liquid chromatography (HPLC). As a blank control, 100 ml fresh assay medium, not previously exposed to cells, was processed in the same way.
The intracellular angiotensins were extracted by the following techniques. Immediately after removal of the medium, 0.2 ml concentrated TFA was added to each dish. The dishes were covered with a lid for 5 minutes and then washed twice with 1 ml of 0.02 M acetic acid. The wash fluids were collected and methanol, 10 mM Na acetate, pH 5.6; solvent B was 80% methanol, 10 mM Na acetate, pH 5.6 Linear gradient is 20 minutes with a flow rate of 1 ml/min. sonicated for 2x10 seconds with a sonicator cell disrupter (Heat Systems-Ultrasonic, Farmingdale, New York). The sonicate was then heated to boiling and further processed in the same manner as the assay medium.
Reverse-phase HPLC was performed using an Ultropac column (2, 3 ,um, 4.6 x50 mm, Spherisorb ODS, LKB, Sweden), and Ang I, Ang II, and Ang III in HPLC fractions were pooled for angiotensin radioimmunoassay, as previously described.9 The Ultropac column was used for both cells and medium. Each assay was performed from the pool of medium or cells of 20 tissue culture dishes. The sensitivity of angiotensin radioimmunoassay is 0.1-1.2 ng per assay.
Statistical Analysis
The values were expressed as mean±+SD. Statistical analysis of data was performed by analysis of variance and the Newman-Keuls test with the IBM PC STAT computer program. A value of p<0.05 was taken as the level of significance.
Results
The separation of Ang (bovine sequence) I, Ang II, and Ang III was achieved by reverse-phase HPLC, as shown in Figure 1 . Ang I, Ang II, and Ang III in BAECs and in their culture media were eluted at identical positions as standard bovine angiotensin in HPLC fractions and were measured by radioimmunoassay with antibodies against human angiotensm. In Figure 2 the antibody-bound/free angiotensin ratio is plotted against the concentrations of unlabeled angiotensin in the incubation mixture. As shown in Figure 2, (Figure 3) .
To study the regulation of angiotensin secretion by adrenergic influence, effects of the a-adrenergic agonist phenylephrine (10-6_10-4 M) on angiotensin secretion were also examined. Incubation of BAECs with phenylephrine for 30 minutes at 370 C inhibited the secretion of angiotensin into the medium in a dose-dependent manner (Figure 4) .
We then examined whether isoproterenol-induced response is mediated by cyclic AMP by testing whether forskolin (10-7-_0-5 M), adenylate cyclase stimulant, mimics the effects induced by isoproterenol. BAECs were incubated with various concentrations of forskolin for 30 minutes at 370 C. Forskolin stimulated angiotensin secretion in a similar fashion as isoproterenol ( Figure 5 ).
We studied the relative contributions of f3l-and 132-adrenoceptor subtypes to the regulation of angiotensin secretion. Angiotensin secretion induced by isoproterenol (10 ,iM) Our data on the /32-adrenergic influence are consistent with the findings of Nakamaru et al17,18 that angiotensin secretion from rat mesenteric arteries was stimulated by a 132-adrenoceptor mechanism. In addition, our data also show that the a-adrenergic agonist phenylephrine inhibits the angiotensin release reaction. Thus, angiotensin secretion from BAECs is regulated by a-and ,B-adrenergic mechanisms. These findings may also have important physiological implications in the role ofvascular angiotensin in mediating/ modulating sympathetic effects on vascular tone.
The origin of each component of the reninangiotensinogen system in the BAEC is not fully known. We have demonstrated that the BAEC is capable of synthesizing renin.8 Angiotensinogen could be either internalized from the medium containing calf serum before replacement with assay medium or synthesized in situ. Our data tend to support the latter mechanism. Neither angiotensinogen nor angiotensins could be detected in the heat-inactivated culture medium.89 The total amount of angiotensin (in the cells plus the media) induced by isoproterenol was greater than that of control at basal level; this finding argues in favor of de novo synthesis. The demonstration of angiotensinogen messenger RNA in BAECs will be strong evidence of local synthesis. By use of a rat complementary DNA probe, our preliminary data have demonstrated angiotensinogen messenger RNA in cultured rat microvascular endothelial cells (unpublished data) but not BAECs. However, since the sequence of bovine angiotensinogen is unknown, it may well be that the rat complementary DNA probe shares a low degree of homology with that of the bovine species and is unable to cross-hybridize with the bovine messenger RNA. Indeed, the amino sequence of bovine Ang II is different from those of human and rat Ang II.
It is well known that Ang I converting enzyme is localized on the plasma membrane. In addition, an intracellular location of ACE is also possible, especially when one considers the fact that this membranebound enzyme is first synthesized intracellularly and then translocated to the cell surface. 
